Helminth therapy or elimination: epidemiological, immunological, and clinical considerations (Q38224936)

31 August 2017

Helminth therapy or elimination: epidemiological, immunological, and clinical considerations (English)

1 reference

31 August 2017

1 reference

Harriet Mpairwe

2

0 references

Alison M Elliott

object named as

Alison M Elliott

series ordinal

3

0 references

Maria Yazdanbakhsh

series ordinal

4

object named as

Maria Yazdanbakhsh

1 reference

31 August 2017

Linda J Wammes

1

1 reference

31 August 2017

26 June 2014

1 reference

Lancet Infectious Diseases

31 August 2017

1 reference

31 August 2017

14

1 reference

31 August 2017

1150-1162

1 reference

31 August 2017

11

1 reference

The knowledge of parasites and parasitic infections from ancient times to the 17th century.

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immuno-epidemiology of human geohelminthiasis: ecological and immunological determinants of worm burden

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Diversity and dialogue in immunity to helminths.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The effect of infections on susceptibility to autoimmune and allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Environmental biodiversity, human microbiota, and allergy are interrelated

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Hay fever, hygiene, and household size

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Innate lymphoid cells--a proposal for uniform nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

CD4 T cells: fates, functions, and faults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Regulatory T cells and infection: a dangerous necessity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Maintaining system homeostasis: the third law of Newtonian immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immunological modulation and evasion by helminth parasites in human populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immune regulation by helminth parasites: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Antigen-specific suppressor cells and suppressor factors in human filariasis with Brugia malayi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Alternatively activated and immunoregulatory monocytes in human filarial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The phenotype and function of naturally existing regulatory dendritic cells in nematode-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Suppressor T cells, rebranded as regulatory T cells, emerge from the wilderness bearing surface markers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Regulatory T cells in infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Regulatory T cell subsets in filarial infection and their function

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The S. mansoni glycoprotein ω-1 induces Foxp3 expression in NOD mouse CD4⁺ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Helminth infections associated with multiple sclerosis induce regulatory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Allergy, parasites, and the hygiene hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Chronic helminth infections protect against allergic diseases by active regulatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Asthma and current intestinal parasite infection: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Do helminth parasites protect against atopy and allergic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The presence of serum anti-Ascaris lumbricoides IgE antibodies and of Trichuris trichiura infection are risk factors for wheezing and/or atopy in preschool-aged Brazilian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Ascaris, atopy, and exercise-induced bronchoconstriction in rural and urban South African children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Clonorchis sinensis infection is positively associated with atopy in endemic area.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The development of TH2 responses from infancy to 4 years of age and atopic sensitization in areas endemic for helminth infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Risk Factors Associated with the Development of Atopic Sensitization in Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Toxocara seropositivity, atopy and wheezing in children living in poor neighbourhoods in urban Latin American

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effects of geohelminth infection and age on the associations between allergen-specific IgE, skin test reactivity and wheeze: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Relationship between different species of helminths and atopy: a study in a population living in helminth-endemic area in Sulawesi, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Association of atopy, asthma, allergic rhinoconjunctivitis, atopic dermatitis and intestinal helminth infections in Cuban children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effects of Helicobacter pylori, geohelminth infection and selected commensal bacteria on the risk of allergic disease and sensitization in 3-year-old Ethiopian children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Helminth Infection Does Not Reduce Risk for Chronic Inflammatory Disease in a Population-Based Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Toxocara seropositivity, atopy and asthma: a study in Cuban schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Toxocara infection and diminished lung function in a nationally representative sample from the United States population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Interactions between helminth parasites and allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Multiple sclerosis and the hygiene hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Association between parasite infection and immune responses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The impact of parasite infections on the course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Infection with a Helminth Parasite Attenuates Autoimmunity through TGF- -Mediated Suppression of Th17 and Th1 Responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Heligmosomoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Rheumatoid arthritis in an urban South African Negro population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Helminth parasites and the modulation of joint inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: comment on the article by Pineda et al

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Does the failure to acquire helminthic parasites predispose to Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Exposure to hookworms in patients with Crohn's disease: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Childhood helminth exposure is protective against inflammatory bowel disease: a case control study in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Translatability of helminth therapy in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Helminth mediated modulation of Type 1 diabetes (T1D).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Type 2 diabetes as an inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Impact of anthelminthic treatment in pregnancy and childhood on immunisations, infections and eczema in childhood: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Clinical improvement of asthma after anthelminthic treatment in a tropical situation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The effect of antihelminthic treatment on subjects with asthma from an endemic area of schistosomiasis: a randomized, double-blinded, and placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The inverse association of salmonellosis in infancy with allergic rhinoconjunctivitis and asthma at school-age: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Farm living: effects on childhood asthma and allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Childhood atopic diseases and early life circumstances: an ecological study in Cuba

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Long-term periodic anthelmintic treatments are associated with increased allergen skin reactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Assessment of frequency, transmission, and genitourinary complications of enterobiasis (pinworms).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Repeated treatments with albendazole enhance Th2 responses to Ascaris Lumbricoides, but not to aeroallergens, in children from rural communities in the Tropics.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Early exposure of infants to GI nematodes induces Th2 dominant immune responses which are unaffected by periodic anthelminthic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Environmental conditions, immunologic phenotypes, atopy, and asthma: new evidence of how the hygiene hypothesis operates in Latin America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Mode of action of benzimidazoles.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Characterisation of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

beta-Tubulin genes and the basis for benzimidazole sensitivity of the opportunistic fungus Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Trichuris suis therapy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Trichuris suis might be effective in treating allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Experimental hookworm infection: a randomized placebo-controlled trial in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Characterising the mucosal and systemic immune responses to experimental human hookworm infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Potential Danger in the Medical Use of Trichuris suis for the Treatment of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Helminth-derived immunomodulators: can understanding the worm produce the pill?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Vaccine against autoimmune disease: can helminths or their products provide a therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Origin, kinetics of circulation and fate in vivo of the major excretory-secretory product of Acanthocheilonema viteae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Metabolic pathways in immune cell activation and quiescence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Macrophages, inflammation, and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

A research and development agenda for the control and elimination of human helminthiases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

Population deworming every 6 months with albendazole in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970771-6

7 January 2021

10.1016/S1473-3099(14)70771-6

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24981042